Low rates of contraception with teratogenic drug use

The study of 470 women recruited from 22 general practices in the UK found one-third of those with type 1 diabetes and two-thirds with type 2 diabetes were prescribed drugs not recommended for use in pregnancy.

The researchers said exposure to statins, angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers during pregnancy was associated with a high prevalence of malformations in newborns.

Yet only 42% of the women were using contraception, even though 54% were prescribed teratogenic drugs.

“The presence